Marino Faccini
Research Subjects
Research Interests
Marino Faccini has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
Sabrina Senatore
Health Protection Agency, Metropolitan Area of Milan, Milan, Italy
4 shared publications- Antonella Amendola
Department of Health Sciences, Università degli Studi di Milano, 20133 Milan, Italy
3 shared publications Chiara Mameli
A Department of Pediatrics; Children's Hospital "V. Buzzi" ; University of Milan ; Milan , Italy
3 shared publications- Fabio Magurano
Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
3 shared publications - Gianvincenzo Zuccotti
Department of Pediatrics Vittore Buzzi Children's Hospital Milan Italy
3 shared publications Laura Daprai
3 shared publications
Latest Publications
- Open Access
- 21 September 2017
- Published by SAGE Publications in Journal of Public Health Research
- Vol. 6 (2) , 955
Validation of a Scale to Measure Parental Psychological Empowerment in the Vaccination Decision
Background and aims: Parents’ empowerment is advocated to promote and preserve an informed and autonomous decision regarding their children’ immunization. The scope of this study is to develop and evaluate the psychometric properties of an instrument to measure parents’ psychological empowerment in their children's vaccination decision and propose a context-specific definition of this construct. Materials and methods: Grounding in previous qualitative data, we generated an initial pool of items which was later content and face validated by a panel of experts. A pretest allowed us to reduce the initial pool to 9 items. Convergent and discriminant validity measures included the General Self-Efficacy Scale, a Psychological Empowerment Scale, and the Control Preference Scale. Vaccination-related outcomes such as attitude and intention were also included. Results: Principal Component Analysis revealed a 2-factor structure, with each factor composed of 2 items. The first factor concerns the perceived influence of one's personal and family experience with vaccination, while the second factor represents the desire not to ask other parents about their experience with vaccination and their lack of interest in other parents’ vaccination opinion. Conclusions: In light of its association with positive immunization-related outcomes, public health efforts should be directed to reinforce parents’ empowerment.
- 21 September 2017
- Published by SAGE Publications in Journal of Public Health Research
- Vol. 6 (2) , 955
Open AccessValidation of a Scale to Measure Parental Psychological Empowerment in the Vaccination Decision
Background and aims: Parents’ empowerment is advocated to promote and preserve an informed and autonomous decision regarding their children’ immunization. The scope of this study is to develop and evaluate the psychometric properties of an instrument to measure parents’ psychological empowerment in their children's vaccination decision and propose a context-specific definition of this construct. Materials and methods: Grounding in previous qualitative data, we generated an initial pool of items which was later content and face validated by a panel of experts. A pretest allowed us to reduce the initial pool to 9 items. Convergent and discriminant validity measures included the General Self-Efficacy Scale, a Psychological Empowerment Scale, and the Control Preference Scale. Vaccination-related outcomes such as attitude and intention were also included. Results: Principal Component Analysis revealed a 2-factor structure, with each factor composed of 2 items. The first factor concerns the perceived influence of one's personal and family experience with vaccination, while the second factor represents the desire not to ask other parents about their experience with vaccination and their lack of interest in other parents’ vaccination opinion. Conclusions: In light of its association with positive immunization-related outcomes, public health efforts should be directed to reinforce parents’ empowerment.
- Open Access
- 17 August 2017
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 22 (33)
Ongoing large measles outbreak with nosocomial transmission in Milan, northern Italy, March–August 2017
A large measles outbreak has been ongoing in Milan and surrounding areas. From 1 March to 30 June 2017, 203 measles cases were laboratory-confirmed (108 sporadic cases and 95 related to 47 clusters). Phylogenetic analysis revealed the co-circulation of two different genotypes, D8 and B3. Both genotypes caused nosocomial clusters in two hospitals. The rapid analysis of epidemiological and phylogenetic data allowed effective surveillance and tracking of transmission pathways.
- 17 August 2017
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 22 (33)
Open AccessOngoing large measles outbreak with nosocomial transmission in Milan, northern Italy, March–August 2017
A large measles outbreak has been ongoing in Milan and surrounding areas. From 1 March to 30 June 2017, 203 measles cases were laboratory-confirmed (108 sporadic cases and 95 related to 47 clusters). Phylogenetic analysis revealed the co-circulation of two different genotypes, D8 and B3. Both genotypes caused nosocomial clusters in two hospitals. The rapid analysis of epidemiological and phylogenetic data allowed effective surveillance and tracking of transmission pathways.
- Open Access
- 1 May 2017
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 23 (5) , 870-872
Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy
Four cases of infection with serogroup X meningococci (MenX) (1 in 2015 and 3 in 2016) occurred in migrants living in refugee camps or reception centers in Italy. All MenX isolates were identified as clonal complex 181. Our report suggests that serogroup X represents an emerging health threat for persons arriving from African countries.
- 1 May 2017
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 23 (5) , 870-872
Open AccessMeningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy
Four cases of infection with serogroup X meningococci (MenX) (1 in 2015 and 3 in 2016) occurred in migrants living in refugee camps or reception centers in Italy. All MenX isolates were identified as clonal complex 181. Our report suggests that serogroup X represents an emerging health threat for persons arriving from African countries.
- 1 November 2016
- Published by Elsevier in Journal of Hospital Infection
- Vol. 94 (3) , 249-252
Hepatitis C virus outbreak in a haemodialysis unit: learning from failures
- 1 November 2016
- Published by Elsevier in Journal of Hospital Infection
- Vol. 94 (3) , 249-252
Hepatitis C virus outbreak in a haemodialysis unit: learning from failures
- 1 October 2016
- Published by Elsevier in American Journal of Infection Control
- Vol. 44 (10) , 1164-1165
Legionnaires' disease contracted from patient workplace: First report of a severe case of coinfection with varicella-zoster virus
- 1 October 2016
- Published by Elsevier in American Journal of Infection Control
- Vol. 44 (10) , 1164-1165
Legionnaires' disease contracted from patient workplace: First report of a severe case of coinfection with varicella-zoster virus
- Open Access
- 19 May 2016
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 21 (20)
Outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016
A measles outbreak occurred from November 2015 to April 2016 in two northern Italian regions, affecting the Roma/Sinti ethnic population and nosocomial setting. Overall, 67 cases were reported. Median age of 43 cases in three Roma/Sinti camps was four years, nosocomial cases were mainly adults. The outbreak was caused by a new measles virus B3.1 variant. Immunisation resources and strategies should be directed at groups with gaps in vaccine coverage, e.g. Roma/Sinti and healthcare workers.
- 19 May 2016
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 21 (20)
Open AccessOutbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016
A measles outbreak occurred from November 2015 to April 2016 in two northern Italian regions, affecting the Roma/Sinti ethnic population and nosocomial setting. Overall, 67 cases were reported. Median age of 43 cases in three Roma/Sinti camps was four years, nosocomial cases were mainly adults. The outbreak was caused by a new measles virus B3.1 variant. Immunisation resources and strategies should be directed at groups with gaps in vaccine coverage, e.g. Roma/Sinti and healthcare workers.
- Open Access
- 9 March 2015
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 11 (4) , 811-817
A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era
Few epidemiological data are available after the introduction of the 13-valent pneumococcal vaccine (PCV13) in 2010. We performed repeat nasopharyngeal swabs and evaluated the serotype distribution of Streptococcus pneumoniae (SP) and its association with PCV13 vaccine status in healthy Italian children aged 3–59 months. SP serotypes were assessed by the Quellung reaction. 618 children appropriately (28%) or incompletely (72%) vaccinated for age with PCV13 were available at baseline (T0). 515 were re-evaluated at 6 months from baseline (T6) and 436 at 12 months from baseline (T12). The percentage of appropriately vaccinated subjects at T0, T6 and T12 was 28%, 67% and 92%, respectively. Random effects logistic regression models with robust 95% confidence intervals was used to estimate the time-related changes in SP and PCV13 carriage and marginal probabilities were obtained from such models. The age-corrected probability of SP carriage was 0.31 (95% CI 0.22 - 0.41) at T0, 0.32 (0.24 - 0.40) at T6 and 0.28 (0.20 - 0.35) at T12. The probability of PCV13 serotypes carriage was 0.025 (0.001 - 0.050) at T0, 0.018 (0.001 - 0.039) at T6 and 0.010 (0.001 - 0.023) at T12. A decrease in PCV13 serotypes and a shift in non-PCV13 serotypes colonization was observed. In particular, the 15A serotype accounted for 4%, 8% and 23% of SP isolates at T0, T6 and T12, respectively. In conclusion, the benefits of the PCV13 vaccination on SP carriage increase with increasing coverage rates. The shift of SP isolates toward non-PCV13 serotypes needs to be studied further.
- 9 March 2015
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 11 (4) , 811-817
Open AccessA longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era
Few epidemiological data are available after the introduction of the 13-valent pneumococcal vaccine (PCV13) in 2010. We performed repeat nasopharyngeal swabs and evaluated the serotype distribution of Streptococcus pneumoniae (SP) and its association with PCV13 vaccine status in healthy Italian children aged 3–59 months. SP serotypes were assessed by the Quellung reaction. 618 children appropriately (28%) or incompletely (72%) vaccinated for age with PCV13 were available at baseline (T0). 515 were re-evaluated at 6 months from baseline (T6) and 436 at 12 months from baseline (T12). The percentage of appropriately vaccinated subjects at T0, T6 and T12 was 28%, 67% and 92%, respectively. Random effects logistic regression models with robust 95% confidence intervals was used to estimate the time-related changes in SP and PCV13 carriage and marginal probabilities were obtained from such models. The age-corrected probability of SP carriage was 0.31 (95% CI 0.22 - 0.41) at T0, 0.32 (0.24 - 0.40) at T6 and 0.28 (0.20 - 0.35) at T12. The probability of PCV13 serotypes carriage was 0.025 (0.001 - 0.050) at T0, 0.018 (0.001 - 0.039) at T6 and 0.010 (0.001 - 0.023) at T12. A decrease in PCV13 serotypes and a shift in non-PCV13 serotypes colonization was observed. In particular, the 15A serotype accounted for 4%, 8% and 23% of SP isolates at T0, T6 and T12, respectively. In conclusion, the benefits of the PCV13 vaccination on SP carriage increase with increasing coverage rates. The shift of SP isolates toward non-PCV13 serotypes needs to be studied further.
- 20 January 2015
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 143 (13) , 2841-2848
Tuberculosis-related stigma leading to an incomplete contact investigation in a low-incidence country
SUMMARY A contact investigation following a case of infectious tuberculosis (TB) reported in a call centre in Milan (Italy) led to the identification of three additional cases that had occurred in employees of the same workplace during the previous 5 years, one of whom was the probable source case. Thirty-three latent infections were also identified. At the time of diagnosis, the source case, because of fear of stigma related to TB, claimed to be unemployed and a contact investigation was not performed in the workplace. Cases were linked through genotyping of Mycobacterium tuberculosis. TB stigma has been described frequently, mainly in high-incidence settings, and is known to influence health-seeking behaviours and treatment adherence. The findings in this report highlight that TB-associated stigma may also lead to incomplete contact investigations. Little is known about the causes and impact of TB-related stigma in low-incidence countries and this warrants further exploration. Research is also needed to evaluate the effectiveness of specific interviewing techniques and training interventions for staff in reducing feelings of stigma in TB patients. Finally, the outbreak emphasizes the importance of integrating routine contact investigations with genotyping.
- 20 January 2015
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 143 (13) , 2841-2848
Tuberculosis-related stigma leading to an incomplete contact investigation in a low-incidence country
SUMMARY A contact investigation following a case of infectious tuberculosis (TB) reported in a call centre in Milan (Italy) led to the identification of three additional cases that had occurred in employees of the same workplace during the previous 5 years, one of whom was the probable source case. Thirty-three latent infections were also identified. At the time of diagnosis, the source case, because of fear of stigma related to TB, claimed to be unemployed and a contact investigation was not performed in the workplace. Cases were linked through genotyping of Mycobacterium tuberculosis. TB stigma has been described frequently, mainly in high-incidence settings, and is known to influence health-seeking behaviours and treatment adherence. The findings in this report highlight that TB-associated stigma may also lead to incomplete contact investigations. Little is known about the causes and impact of TB-related stigma in low-incidence countries and this warrants further exploration. Research is also needed to evaluate the effectiveness of specific interviewing techniques and training interventions for staff in reducing feelings of stigma in TB patients. Finally, the outbreak emphasizes the importance of integrating routine contact investigations with genotyping.
- 31 December 2014
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 45 (1) , 292-294
Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal
- 31 December 2014
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 45 (1) , 292-294
Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal